These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21218537)

  • 1. Ask the doctor. I read that angiotensin-receptor blockers cause cancer. I take one (Diovan) for my blood pressure. Should I stop?
    Lee T
    Harv Heart Lett; 2010 Dec; 21(4):8. PubMed ID: 21218537
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 3. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
    MMW Fortschr Med; 2006 Sep; 148(38):17. PubMed ID: 17036956
    [No Abstract]   [Full Text] [Related]  

  • 5. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin receptor blockers: dose does matter.
    Sarzani R; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 Mar; 26(3):607-8; author reply 608. PubMed ID: 18300874
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of AT1-angiotensin II receptor blocker valsartan in clinical practice].
    Maksimov ML; Mochkin IA; Starodubtsev AK
    Kardiologiia; 2011; 51(8):77-84. PubMed ID: 21942964
    [No Abstract]   [Full Text] [Related]  

  • 10. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin receptor blockers and myocardial infarction.
    Verma S; Strauss M
    BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
    [No Abstract]   [Full Text] [Related]  

  • 12. Lithium intoxication after valsartan treatment.
    Su YP; Chang CJ; Hwang TJ
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):204. PubMed ID: 17362443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of valsartan-eluting stents on the expression of angiotensin II type 2 receptor.
    Wang L; Li GH; Chen H; Li HW; Zhao L; Yao DK; Ding RJ; Jia SQ
    Chin Med J (Engl); 2006 Apr; 119(7):601-4. PubMed ID: 16620703
    [No Abstract]   [Full Text] [Related]  

  • 15. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W
    MMW Fortschr Med; 2004 Jul; 146(27-28):41. PubMed ID: 15526662
    [No Abstract]   [Full Text] [Related]  

  • 17. Valsartan inefficacy or ill-effects of concomitant medications!
    Bangalore S; Messerli FH
    Am J Cardiol; 2010 Aug; 106(4):602-3. PubMed ID: 20691326
    [No Abstract]   [Full Text] [Related]  

  • 18. [Creatively revised quotation on sale arguments concerning Diovan (valsartan].
    Andersen SE; Pedersen ST
    Ugeskr Laeger; 2000 Nov; 162(47):6430. PubMed ID: 11116460
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):335-43. PubMed ID: 15030262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M; Müller U; Böhm M
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.